other Cancer Research Results

other, other: Click to Expand ⟱
Source:
Type:
custom
Ovarian, Ovarian Cancer: Click to Expand ⟱
Ovarian Cancer
Scientific Papers found: Click to Expand⟱
7996- itraC,    Itraconazole in the Treatment of Aberrantly Active Hedgehog and/or PI3K Recurrent Ovarian Cancer
- Trial, Ovarian, NA
HH↓, PI3K↓, toxicity↝, eff∅, CA125∅, other↝,
8018- itraC,  Chemo,    Impact of combination chemotherapy with itraconazole on survival of patients with refractory ovarian cancer
- Trial, Ovarian, NA
PFS↑, OS↑, other↝,
4747- Se,  Chemo,  antiOx,    Phase I trial of selenium plus chemotherapy in gynecologic cancers
- Trial, Ovarian, NA
*toxicity↓, ChemoSen∅, RAD51↓, other↝,

Showing Research Papers: 1 to 3 of 3

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

PFS↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

other↝, 3,  

DNA Damage & Repair(tgid=10) ⓘ

RAD51↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

HH↓, 1,   PI3K↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ChemoSen∅, 1,   eff∅, 1,  

Clinical Biomarkers(tgid=22) ⓘ

CA125∅, 1,  

Functional Outcomes(tgid=23) ⓘ

OS↑, 1,   toxicity↝, 1,  
Total Targets: 10

Pathway results for Effect on Normal Cells:


Functional Outcomes(tgid=23) ⓘ

toxicity↓, 1,  
Total Targets: 1

Scientific Paper Hit Count for: other, other
2 itraconazole
2 Chemotherapy
1 Selenium
1 Anti-oxidants
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:20  Cells:%  prod#:%  Target#:767  State#:%  Dir#:4
  wNotes=0  sortOrder:rid,rpid

 

Home Page